4-(4-beta-(5-methylisoxazol-3-carboxamidoethyl)phenylsulfonyl)-1,1-hexamethylenesemicarbazide,
BS 4231,
BS-4231,
glisoxepid,
glisoxepide,
Pro-diaban,
RP 22410,
RP-22410,
3-(4-ethylphenyl)-1H-pyrazole-5-carboxylic acid,
890591-84-1,
1197631-25-6,
5-(4-Ethylphenyl)-1H-pyrazole-3-carboxylic acid,
5-(4-ethylphenyl)-2H-pyrazole-3-carboxylic Acid,
MLS-0091992.0001,
1H-Pyrazole-5-carboxylicacid, 3-(4-ethylphenyl)-,
3-(4-ethylphenyl)pyrazole-5-carboxylic acid,
AC1Q2TGQ,
AC1MRV13,
SCHEMBL1413995,
CHEMBL1412304,
BDBM45835,
cid_3524248,
CTK3E7210,
KS-00001NGE,
DTXSID10393298,
ALBB-006661,
KS-00003HT4,
ZINC6848733,
BBL012391,
HTS000460,
MFCD03030350,
SBB039941,
STK392455,
AKOS000266683,
AKOS009040466,
BS-4231,
MCULE-5239712511,
AJ-71108,
DB-029338,
BB 0219101,
FT-0679241,
ST50160605,
EN300-41430,
Y-1628,
5-(4-Ethyl-phenyl)-2H-pyrazole-3-carboxylic acid,
I04-4018,
F3250-0665,
C12H12N2O2,
CID3524248,
2,3-dihydro-1H-inden-2-yl(methyl)amine,